In multivariable-adjusted analyses, these associations with survival changed direction but did not reach statistical significance (CRC-specific survival: HR adjuvant therapy 0.86; 95% 0.65–1.14; overall survival: HR adjuvant therapy 0.82; 95% CI 0.64–1.05; Table 2 ).
← all excerpts
Association between adjuvant therapy and survival in colorectal cancer patients according to metabolic Warburg-subtypes.
1
—
—